Cargando…
Cangfu Daotan Wan alleviates polycystic ovary syndrome with phlegm-dampness syndrome via disruption of the PKP3/ERCC1/MAPK axis
BACKGROUND/AIM: Cangfu Daotan Wan (CFDTW) has been widely used for polycystic ovary syndrome (PCOS) patients in the type of stagnation of phlegm and dampness. In this study, we aimed to evaluate the mechanism underlying the therapeutic effect of CFDTW on PCOS with phlegm-dampness syndrome (PDS). MET...
Autores principales: | Li, Yuan, Wu, Haicui, Guo, Ying, Wei, Chaofeng, Guan, Lu, Ju, Wenhan, Lian, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327183/ https://www.ncbi.nlm.nih.gov/pubmed/37420272 http://dx.doi.org/10.1186/s13048-023-01200-7 |
Ejemplares similares
-
Cangfu daotan decoction for polycystic ovary syndrome: A protocol of systematic review and meta-analysis
por: Park, Hye-Rin, et al.
Publicado: (2019) -
Efficacy and Safety of Cangfu Daotan Decoction in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Wu, Linling, et al.
Publicado: (2022) -
Modified Cangfu Daotan decoction ameliorates polycystic ovary syndrome with insulin resistance via NF-κB/LCN-2 signaling pathway in inflammatory microenvironment
por: Liu, Shuowen, et al.
Publicado: (2022) -
Study on the Intervention Effect of Qi Gong Wan Prescription on Patients with Phlegm-Dampness Syndrome of Polycystic Ovary Syndrome Based on Intestinal Flora
por: Zhang, Ning, et al.
Publicado: (2020) -
Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology
por: Xu, Wenting, et al.
Publicado: (2020)